Increased nuchal translucency at 11-13 weeks' gestation and pregnancy outcome in twin pregnancies.
To investigate the value of increased fetal nuchal translucency thickness (NT) at the 11-13 weeks scan in the prediction of adverse outcome in dichorionic (DC), monochorionic diamniotic (MCDA) and monochorionic monoamniotic (MCMA) twin pregnancies. This was a retrospective analysis of prospectively collected data on twin pregnancies undergoing routine ultrasound examination at 11-13 weeks' gestation between 2002 and 2019. In pregnancies with no major defects or chromosomal abnormalities we examined the value of increased NT ≥95th percentile in one or both fetuses in the prediction of first, miscarriage or death of one or both fetuses at <20 and <24 weeks' gestation in DC, MCDA and MCMA twin pregnancies, second, death of one or both fetuses or neonates at ≥24 weeks in DC, MCDA and MCMA twin pregnancies, third, development of twin-to-twin transfusion syndrome (TTTS) or selective fetal growth restriction (sFGR) treated by endoscopic laser surgery at <20 and ≥20 weeks' gestation in MCDA pregnancies, and fourth, either fetal loss or laser surgery at <20 weeks' gestation. The study population of 6,225 twin pregnancies included 4,896 (78.7%) DC, 1,274 (20.4%) MCDA and 55 (0.9%) MCMA. The incidence of NT ≥95th percentile in one or both fetuses in DC twin pregnancies was 8.3%; in MCDA twins the incidence was significantly higher (10.4%, P=0.016), but in MCMA twins it was not significantly different from that in DC twins (9.1% P=0.804). In DC twin pregnancies the incidence of high NT was not significantly different between those with two survivors and those with adverse outcome. In MCMA twin pregnancies the number of cases was too small for meaningful assessment of the relation between high NT and adverse outcome. In MCDA twin pregnancies with ≥1 fetal death or need for endoscopic laser surgery at <20 weeks' gestation the incidence of NT ≥95th percentile was significantly higher than in pregnancies with two survivors (23.5% versus 9.8%, P <0.0001). Kaplan-Meier analysis in MCDA twin pregnancies showed that in those with NT ≥95th percentile there was a significantly lower survival at <20 weeks' gestation than in those with NT <95th percentile (P=0.001); this was not the case for survival at ≥20 weeks (P=0.960). The performance of screening by fetal NT ≥95th for prediction of either fetal loss or need for endoscopic laser surgery at <20 weeks' gestation was poor with detection rate of 23.5% at false positive rate of 8.9% and the relative risk, by comparison with fetal NT <95th percentile was 2.640 (95% CI, 1.854-3.758; P<0.0001). In MCDA twin pregnancies the overall rate of fetal loss or need for laser surgery at <20 weeks' gestation was 10.7% but in the subgroups with NT ≥95th and NT ≥99th percentiles, which constituted 10.4% and 3.3% of the total, the rates increased to 24.1% and 40.5%, respectively. In MCDA twin pregnancies with no major fetal abnormalities measurement of NT at the 11-13 weeks scan is a poor screening test for adverse pregnancy outcome. However, the finding in one or both fetuses of NT ≥95th percentile, and more so ≥99th percentile, is associated with a substantially increased risk of fetal loss or need for endoscopic laser surgery at <20 weeks' gestation. The extent to which closer monitoring and earlier intervention in the high-risk group can reduce these complications remains to be determined. This article is protected by copyright. All rights reserved.